Clinical trials
Phase 3 Inflammatory Bowel Diseases trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| InDex Pharmaceuticals | 1 |
| Janssen Biotech, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Ocera Therapeutics | 1 |
| Pfizer | 1 |
| Warner Chilcott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 13 |
| Colitis, Ulcerative | 7 |
| Crohn Disease | 6 |
| Colitis | 2 |
| Fistula | 1 |
| Gastrointestinal Diseases | 1 |
| Intestinal Fistula | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.